Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs

References

• Gould P. (1986). Salt selection for basic drugs. Int J Pharm, 33:201–217.
   Web of Science ®Google Scholar
• Serajuddin AT. (2007). Salt formation to improve drug solubility. Adv Drug Deliv Rev, 59:603–616.
   PubMed Web of Science ®Google Scholar
• Stahl PH, Wermuth G. (2002). Handbook of pharmaceutical salts: properties, selection, and use. Wiley-VCH, Zurich.
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46:3–26.
   PubMed Web of Science ®Google Scholar
• Bastin RJ, Bowker MJ, Slater BJ. (2000). Salt selection and optimization procedures for pharmaceutical new chemical entities. Org Proc Res Dev, 4:427–435.
   Web of Science ®Google Scholar
• Black SN, Collier EA, Davey RJ, Roberts RJ. (2007). Structure, solubility, screening, and synthesis of molecular salts. J Pharm Sci, 96:1053–1068.
   PubMed Web of Science ®Google Scholar
• Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ., Spagnuluo CG, Serajuddin ATM. (1994). An integrated approach to the selection of optimal salt form for a new drug candidate. Int J Pharm, 105:209–217.
   Web of Science ®Google Scholar
• Lee T, Wang YW. (2009). Initial salt screening procedures for manufacturing ibuprofen. Drug Dev Ind Pharm, 35:555–567.
   PubMed Web of Science ®Google Scholar
• Datta S, Grant DJ. (2004). Crystal structures of drugs: advances in determination, prediction and engineering. Nat Rev Drug Discov, 3:42–57.
   PubMed Web of Science ®Google Scholar
• York P. (1992). Crystal engineering and particle design for the powder compaction process. Drug Dev Ind Pharm, 18:677–721.
   Web of Science ®Google Scholar
• Paulekuhn GS, Dressman JB, Saal C. (2007). Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database. J Med Chem, 50:6665–6672.
   PubMed Web of Science ®Google Scholar
• Guerrieri P, Rumondor AC, Li T, Taylor LS. (2010). Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts. AAPS Pharmscitech, 11:1212–1222.
   PubMed Web of Science ®Google Scholar
• Chowan ZT. (1978). pH-solubility profiles of organic carboxylic acids and their salts. J Pharm Sci, 67:1257–1260.
   PubMed Web of Science ®Google Scholar
• Anderson BD, Conradi RA. (1985). Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J Pharm Sci, 74:815–820.
   PubMed Web of Science ®Google Scholar
• Forbes RT, York P, Davidson JR. (1995). Dissolution kinetics and solubilities of p-aminosalicylic acid and its salts. Int J Pharm, 126:199–208.
   Web of Science ®Google Scholar
• Cheong HA, Choi HK. (2002). Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines. Pharm Res, 19:1375–1380.
   PubMed Web of Science ®Google Scholar
• O’Connor KM, Corrigan OI. (2001). Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. Int J Pharm, 222:281–293.
   PubMed Web of Science ®Google Scholar
• O’Connor KM, Corrigan OI. (2001). Preparation and characterisation of a range of diclofenac salts. Int J Pharm, 226:163–179.
   PubMed Web of Science ®Google Scholar
• Fini A, Fazio G, Fetoci G. (1995). Solubility and solubilization properties of non-steroidal anti-inflammatory drugs. Int J Pharm, 126:95–102.
   Web of Science ®Google Scholar
• Fini A, Fazio G, Benetti L, Ghedini V. (2007). Thermal analysis of some diclofenac salts with alkyl and alkylhydroxy amines. Thermochim Acta, 464:65–74.
   Web of Science ®Google Scholar
• Gu L, Strickley RG. (1987). Preformulation salt selection. Physical property comparisons of the tris(hydroxymethyl)aminomethane (THAM) salts of four analgesic/antiinflammatory agents with the sodium salts and the free acids. Pharm Res, 4:255–257.
   PubMed Web of Science ®Google Scholar
• Shaw LR, Irwin WJ, Grattan TJ, Conway BR. (2005). The effect of selected water-soluble excipients on the dissolution of paracetamol and ibuprofen. Drug Dev Ind Pharm, 31:515–525.
   PubMed Web of Science ®Google Scholar
• Silverstein RM, Webster FX. (1998). Spectrometric identification of organic compounds. John Wiley & Sons, New York, USA.
   Google Scholar
• Palomo ME, Ballesteros MP, Frutos P. (1999). Analysis of diclofenac sodium and derivatives. J Pharm Biomed Anal, 21:83–94.
   PubMed Web of Science ®Google Scholar
• Socrates G. (1994). Infrared characteristic group frequencies. John Wiley & Sons, New York, USA.
   Google Scholar
• Yalkowsky SH. (1981). Solubility and partitioning V: dependence of solubility on melting point. J Pharm Sci, 70:971–973.
   PubMed Web of Science ®Google Scholar
• Yalkowsky SH, Flynn GL, Slunick TG. (1972). Importance of chain length on physicochemical and crystalline properties of organic homologs. J Pharm Sci, 61:852–857.
   PubMed Web of Science ®Google Scholar
• Forster S, Buckton G, Beezer AE. (1991). The importance of chain length on the wettability and solubility of organic homologs. Int J Pharm, 72:29–34
   Web of Science ®Google Scholar
• Dean PM, Golding JJ, Pringle JM, Forsyth M, Skelton BW, White AH, MacFarlane DR. (2009). The effect of alkyl chain length in a series of novel N-alkyl-3-benzylimidazolium iodide salts. Cryst Eng Comm, 11:2456–2465.
   Web of Science ®Google Scholar
• Thomas E, Rubino J. (1996). Solubility, melting point and salting-out relationships in a group of secondary amine hydrochloride salts. Int J Pharm, 130:179–185.
   Web of Science ®Google Scholar
• Wells JI, Aulton, ME.(2007). Pharmaceutical Preformulation. In Aulton ME ed. Pharmaceutics: The design and manufacture of medicines. London: Elsevier, 336–360.
   Google Scholar
• Callahan JC, Cleary GW, Elefant M, Kaplan G, Kensler T, Nash RA. (1982). Equilibrium moisture content of pharmaceutical excipients. Drug Dev Ind Pharm, 8:355–69.
   Web of Science ®Google Scholar
• Balbach S, Korn C. (2004). Pharmaceutical evaluation of early development candidates “the 100 mg-approach”. Int J Pharm, 275:1–12.
   PubMed Web of Science ®Google Scholar
• Sun CC. (2005). True density of microcrystalline cellulose. J Pharm Sci, 94:2132–2134.
   PubMed Web of Science ®Google Scholar
• Heckel RW. (1961). Density–pressure relations in powder compaction. Trans Metallogr Soc AIME, 221:671–675.
   Google Scholar
• Sun CC. (2005). Quantifying errors in tableting data analysis using the Ryshkewitch equation due to inaccurate true density. J Pharm Sci, 94:2061–2068.
   PubMed Web of Science ®Google Scholar
• Ledwidge MT. (1997). The effects of pH, crystalline phase and salt formation on the solubility of ionisable drugs. University of Dublin, Dublin, Ireland. PhD thesis.
   Google Scholar
• Agharkar S, Lindenbaum S, Higuchi T. (1976). Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of an antimalarial drug. J Pharm Sci, 65:747–749.
   PubMed Web of Science ®Google Scholar
• Parshad H, Frydenvang K, Liljefors T, Sorensen HO, Larsen C. (2004). Aqueous solubility study of salts of benzylamine derivatives and p-substituted benzoic acid derivatives using X-ray crystallographic analysis. Int J Pharm, 269:157–168.
   PubMed Web of Science ®Google Scholar
• Fini A, Fazio G, Fernandez-Hervas MJ, Holgado MA, Rabasco AM. (1996). Factors governing the dissolution of diclofenac salts. Eur J Pharm Sci, 4:231–238.
   Web of Science ®Google Scholar
• Cheung EY, David SE, Harris KDM, Conway BR, Timmins P. (2007). Structural properties of a family of hydrogen-bonded co-crystals formed between gemfibrozil and hydroxy derivatives of t-butylamine, determined directly from powder X-ray diffraction data. J Solid State Chem, 180:1068–1075.
   Web of Science ®Google Scholar
• David SE, Ramirez M, Timmins P, Conway BR. (2010). Comparative physical, mechanical and crystallographic properties of a series of gemfibrozil salts. J Pharm Pharmacol, 62:1519–1525.
   PubMed Web of Science ®Google Scholar
• Luner PE, Babu SR, Radebaugh GW. (1994). The effect of bile salts and lipids on the physicochemical behaviour of gemfibrozil. Pharm Res, 11:1755–1760.
   PubMed Web of Science ®Google Scholar
• David SE, Timmins P, Irwin WJ, Conway BR. (2005). The effect of added counterions on the mechanical properties of a poorly compressible drug, gemfibrozil. Proc Pharm Sci Fair, Nice, 2005.
   Google Scholar
• Lee YJ, Padula J, Lee HK. (1988). Kinetics and mechanisms of etodolac degradation in aqueous solutions. J Pharm Sci, 77:81–86.
   PubMed Web of Science ®Google Scholar
• Gerbino PP. (2006). Remington: The Science and Practice of Pharmacy, 21st Ed., Philadelphia, PA. Lippincott, Williams & Wilkins.
   Google Scholar
• Slater B, McCormack A, Avdeef A, Comer JE. (1994). pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values. J Pharm Sci, 83:1280–1283.
   PubMed Web of Science ®Google Scholar